Endolysosomal dysfunction has been noticed as an important pathological feature in AD and multiple endolysosomal genes have been associated with AD risk, such as SORL1, BIN1, and CD2AP [85, 86]. This evidence concerns the gene SORL1 and Alzheimer disease.